report, page-72

I suspect it may have a lot to do with the required capital raising.

Say, you wanted to limit the amount that APG can raise this financial year. They work out how many shares the company has left to issue before an EGM approval is required and multiply that number by the current share price less say a 10% discount.

Guess what, that would very much limit the amount the company can raise to complete testing (caps the amount at below $2.5m).

Now I wonder who has an interest in starving the company of cash? Perhaps a potential bidder or someone who otherwise enjoys inflicting pain.

I'm still confident the company can raise the cash to give the market the assurance that the plant will be fully funded to completion.

So in the end I'm of the view that any manipulation or skullduggery will come to nought.